Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 2/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | CASP1 | P29466 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 3/20 | 0.41 |
| ▸ | HTT | P42858 | 2/20 | 0.41 |
| ▸ | MAOA | P21397 | 1/20 | 0.40 |
| ▸ | ABL1 | P00519 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.39 |
| ▸ | MEN1 | O00255 | 4/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.39 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.39 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7492153 | 0.85 | HTT (0.44) | MAOBCA12CA9SMN1; SMN2HPGD | |
| SCHEMBL10334495 | 0.85 | SMN1; SMN2 (0.57) | SMN1; SMN2TSHRCASP1ALDH1A1MEN1 | |
| SCHEMBL8607500 | 0.85 | SMN1; SMN2 (0.42) | MAOBSMN1; SMN2TSHRCASP1HPGD | |
| SCHEMBL4096751 | 0.83 | KDM4E (0.50) | SMN1; SMN2TSHRCASP1HPGDHTT | |
| SCHEMBL12514051 | 0.81 | L3MBTL1 (0.41) | MAOBCA12CA9SMN1; SMN2TSHR | |
| SCHEMBL30004019 | 0.78 | MCL1 (0.47) | SMN1; SMN2TSHRHPGDALDH1A1KMT2A | |
| SCHEMBL11852003 | 0.78 | MCL1 (0.47) | SMN1; SMN2TSHRHPGDALDH1A1KMT2A | |
| SCHEMBL11705929 | 0.78 | PDE7A (0.48) | CA12CA9SMN1; SMN2TSHRCASP1 | |
| SCHEMBL20117002 | 0.77 | ALDH1A1 (0.50) | MAOBCA12CA9SMN1; SMN2TSHR | |
| SCHEMBL8179274 | 0.77 | ALDH1A1 (0.39) | SMN1; SMN2TSHRCASP1HPGDHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9902742-B2 | Macrocycles as factor XIa inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2018-02-27 | — | — | US | disclosed |
| US-20170158712-A1 | NOVEL MACROCYCLES AS FACTOR XIA INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2017-06-08 | — | — | US | disclosed |
| US-6013839-A | REACTING A 2,4-DIHALOACETOPHENONE WITH A THIOLATING AGENT UNDER ANHYDROUS CONDITIONS; EFFICIENCY; INTERMEDIATES OF HERBICIDES E.G., BENZAMIDE DERIVATIVES | RHONE-POULENC AGRICULTURE LIMITED (GB) | 2000-01-11 | — | — | US | disclosed |
| EP-0883605-A1 | PROCESS FOR PREPARING 2-(THIOSUBSTITUTED)-4-HALOACETOPHENONES | RHONE-POULENC AGRICULTURE LTD. (GB) | 1998-12-16 | — | — | EP | disclosed |
| WO-1997030026-A1 | PROCESS FOR PREPARING 2-(THIOSUBSTITUTED)-4-HALOACETOPHENONES | RHONE-POULENC AGRICULTURE LIMITED (GB) | 1997-08-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170158712-A1 | NOVEL MACROCYCLES AS FACTOR XIA INHIBITORS | TFPI, TFPI2, F12 | MAOB 1387/4885CA12 2004/4885CA9 1527/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.